Pujol, P.; Yauy, K.; Coffy, A.; Duforet-Frebourg, N.; Gabteni, S.; Daurès, J.-P.; Penault Llorca, F.; Thomas, F.; Hughes, K.; Turnbull, C.;
et al. Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation. Cancers 2022, 14, 3266.
https://doi.org/10.3390/cancers14133266
AMA Style
Pujol P, Yauy K, Coffy A, Duforet-Frebourg N, Gabteni S, Daurès J-P, Penault Llorca F, Thomas F, Hughes K, Turnbull C,
et al. Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation. Cancers. 2022; 14(13):3266.
https://doi.org/10.3390/cancers14133266
Chicago/Turabian Style
Pujol, Pascal, Kevin Yauy, Amandine Coffy, Nicolas Duforet-Frebourg, Sana Gabteni, Jean-Pierre Daurès, Frédérique Penault Llorca, Frédéric Thomas, Kevin Hughes, Clare Turnbull,
and et al. 2022. "Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation" Cancers 14, no. 13: 3266.
https://doi.org/10.3390/cancers14133266
APA Style
Pujol, P., Yauy, K., Coffy, A., Duforet-Frebourg, N., Gabteni, S., Daurès, J.-P., Penault Llorca, F., Thomas, F., Hughes, K., Turnbull, C., Galibert, V., Rideau, C., Corsini, C., Collet, L., You, B., Geneviève, D., & Philippe, N.
(2022). Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation. Cancers, 14(13), 3266.
https://doi.org/10.3390/cancers14133266